Published in Psychoneuroendocrinology on October 01, 1978
Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci (2007) 1.47
Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications. Cell Metab (2014) 0.92
Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol (1980) 0.87
The association between naltrexone treatment and symptoms of depression in opioid-dependent patients. Am J Drug Alcohol Abuse (2010) 0.86
Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence. J Psychiatry Neurosci (2006) 0.83
Improving clinical outcomes for naltrexone as a management of problem alcohol use. Br J Clin Pharmacol (2013) 0.78
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human. Int J Neuropsychopharmacol (2014) 0.78
Touch Perception Altered by Chronic Pain and by Opioid Blockade. eNeuro (2016) 0.77
Opioid-receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals. Psychopharmacology (Berl) (2016) 0.75
Behavioral studies of sleep patterns in alcoholics during intoxication and withdrawal. J Pharmacol Exp Ther (1970) 2.45
Management of cocaine abuse and dependence. N Engl J Med (1996) 2.24
2,4-Thiazolidinediones as potent and selective human beta3 agonists. Bioorg Med Chem Lett (2001) 1.71
Adrenal function and alcoholism. I. Serum cortisol. Psychosom Med (1971) 1.62
Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther (1997) 1.52
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (2006) 1.50
Marihuana attenuates the rise in plasma ethanol levels in human subjects. Neuropsychopharmacology (1992) 1.47
Buprenorphine effects on human heroin self-administration: an operant analysis. J Pharmacol Exp Ther (1982) 1.46
Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA (1996) 1.44
Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. J Nucl Med (1995) 1.43
Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology (Berl) (1996) 1.38
Synthesis and opioid receptor affinity of morphinan and benzomorphan derivatives: mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine dependence. J Med Chem (2000) 1.35
Age-related reduction in functional MRI response to photic stimulation. Neurology (1997) 1.34
Reduction in BOLD fMRI response to primary visual stimulation following alcohol ingestion. Psychiatry Res (1998) 1.32
Behavioral toxicology: a developing discipline. Fed Proc (1975) 1.32
Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther (1998) 1.31
Influence of baseline hematocrit and hemodilution on BOLD fMRI activation. Magn Reson Imaging (2001) 1.29
Buprenorphine suppresses heroin use by heroin addicts. Science (1980) 1.27
Liquid-gel chromatography on lipophilic-hydrophobic Sephadex derivatives. J Lipid Res (1970) 1.26
Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther (1999) 1.25
Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA (1998) 1.23
Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology (1999) 1.22
Opiate use and sexual function. Am J Psychiatry (1980) 1.20
Operant analysis of human heroin self-administration and the effects of naltrexone. J Pharmacol Exp Ther (1981) 1.17
Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology (Berl) (1999) 1.17
Cigarette smoking by women: interactions with alcohol use. Psychopharmacology (Berl) (1987) 1.16
Blood concentrations of acetaldehyde and ethanol in chronic alcoholics. Science (1970) 1.15
Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science (1989) 1.14
Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav (1997) 1.13
Experimentally induced intoxication in alcoholics: a comparison between programed and spontaneous drinking. J Pharmacol Exp Ther (1970) 1.11
Interhemispheric transfer of a discrimination of moving patterns in pigeon. Brain Res (1968) 1.11
Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther (2001) 1.11
Comparative psychophysiological studies of alcoholic and nonalcoholic subjects undergoing experimentally induced ethanol intoxication. Psychosom Med (1966) 1.11
Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement. J Pharmacol Exp Ther (1999) 1.11
A versatile lipophilic Sephadex derivative for "reversed-phase" chromatography. Biochim Biophys Acta (1968) 1.07
Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men. Neuropsychopharmacology (1998) 1.06
Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan. Bioorg Med Chem Lett (2001) 1.06
Effects of heroin self-administration on cigarette smoking. Psychopharmacology (Berl) (1980) 1.06
Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. J Pharmacol Exp Ther (1977) 1.05
A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther (1995) 1.05
Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology (Berl) (2000) 1.05
Buprenorphine effects on cigarette smoking. Psychopharmacology (Berl) (1985) 1.04
Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. J Pharmacol Exp Ther (2009) 1.03
Adrenal function and alcoholism. II. Catecholamines. Psychosom Med (1971) 1.02
Experimental analysis of drinking behavior of chronic alcoholics. Ann N Y Acad Sci (1966) 1.01
Acute alcohol effects on plasma estradiol levels in women. Psychopharmacology (Berl) (1988) 0.99
Interocular generalization: a study of mirror-image reversal following monocular discrimination training in the pigeon. J Exp Anal Behav (1966) 0.99
Biologic concomitants of alcoholism. 1. N Engl J Med (1970) 0.98
Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology (Berl) (2000) 0.98
Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol (2000) 0.98
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther (1992) 0.98
Medical progress. Biologic concomitants of alcoholism. N Engl J Med (1979) 0.97
Drinking patterns during work-contingent and noncontingent alcohol acquisition. Psychosom Med (1972) 0.96
Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys. Drug Alcohol Depend (1988) 0.96
Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med (1994) 0.96
Effects of marihuana use on body weight and caloric intake in humans. Psychopharmacology (Berl) (1976) 0.96
Kappa opioid agonists as targets for pharmacotherapies in cocaine abuse. Pharm Acta Helv (2000) 0.94
Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther (1996) 0.94
Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med (1995) 0.93
Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use. Psychopharmacology (Berl) (1984) 0.93
Alcoholism and prevalence of medical and psychiatric disorders. J Stud Alcohol (1986) 0.93
Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther (1999) 0.92
Mirror-image reversal in pigeons. Science (1965) 0.92
Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology (Berl) (1998) 0.92
Operant acquisition of marihuana by women. J Pharmacol Exp Ther (1985) 0.92
Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther (1988) 0.91
Regional cerebral blood flow improves with treatment in chronic cocaine polydrug users. J Nucl Med (1993) 0.91
Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther (1975) 0.91
Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys. J Pharmacol Exp Ther (1999) 0.90
Behavioral and EEG studies of acute cocaine administration: comparisons with morphine, amphetamine, pentobarbital, nicotine, ethanol and marijuana. NIDA Res Monogr (1989) 0.90
Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med (1996) 0.90
Alcohol, affect, and the disinhibition of verbal behavior. Psychopharmacology (Berl) (1983) 0.90
Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J Pharmacol Exp Ther (1983) 0.90
Alcohol use and premenstrual symptoms in social drinkers. Psychopharmacology (Berl) (1990) 0.90